The Scientific and Research Team at Ribon Therapeutics is responsible for discovering and developing innovative small molecule inhibitors targeting cancer cells' survival mechanisms under stress. This team conducts critical research, provides expert scientific guidance, manages lab operations, and leverages extensive scientific advisory to advance Ribon’s clinical-stage biotechnology initiatives.